AI assistant
Sending…
Immunovant, Inc. — Director's Dealing 2025
Apr 28, 2025
31436_dirs_2025-04-28_8e0452b0-ceed-4f26-a0a3-77c35565d367.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Immunovant, Inc. (IMVT)
CIK: 0001764013
Period of Report: 2025-04-18
Reporting Person: Susman Robert Graham (N/A)
More from Immunovant, Inc.
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 6
Interim / Quarterly Report
2026
Feb 6
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 9
Director's Dealing
2025
Dec 19
Regulatory Filings
2025
Dec 12